(Q52106605)

22 April 2018

title

Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients. (English)

1 reference

22 April 2018

1 reference

Fong OW

1

1 reference

22 April 2018

Ho CF

2

1 reference

22 April 2018

Fung LY

3

1 reference

22 April 2018

Lee FK

4

1 reference

22 April 2018

Tse WH

5

1 reference

22 April 2018

Yuen CY

6

1 reference

22 April 2018

Sin KP

7

1 reference

22 April 2018

Wong KH

8

1 reference

22 April 2018

publication date

1 April 2003

1 reference

22 April 2018

published in

HIV Medicine

1 reference

22 April 2018

volume

4

1 reference

22 April 2018

issue

2

1 reference

22 April 2018

page(s)

133-138

1 reference

22 April 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Strategies for long-term success in the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Factors affecting adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Management of the adverse effects of antiretroviral therapy and medication adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Adherence to combination antiretroviral therapies in HIV patients of low health literacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

A comparison study of multiple measures of adherence to HIV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Patient self-report as a marker of adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00147.X

10.1046/J.1468-1293.2003.00147.X

21 January 2018

Identifiers

DOI

1 reference

22 April 2018

1 reference

22 April 2018